A dynamic view of mHLA-DR expression in management of severe septic patients

Critical Care

Volumn 15, Issue 5, 2011, Pages

  Monneret, Guillaume ^a,b   Lepape, Alain ^b,c   Venet, Fabienne ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HLA ANTIGEN; MONOCYTE HLA DR ANTIGEN; UNCLASSIFIED DRUG; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; DISEASE SEVERITY; HLA SYSTEM; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION RISK; MORTALITY; NOTE; PATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SURVIVAL; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MONOCYTE;

FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MONOCYTES; SEPSIS;

EID: 80054110835     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10452     Document Type: Note

References (11)

1. Wu J-F, Jie Ma JC, Ou-Yang B, Chen M-Y, Li LF, Liu Y-J, Lin A-H, Guan X-D. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care 2011, 15:R220. 10.1186/cc10457, 21933399.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150. 10.1056/NEJMra021333, 12519925.
3. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78. 2078557, 18026569.
4. Monneret G, Venet F, Kullberg BJ, Netea MG. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 2011, 49(Suppl 1):S17-S23.
5. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009, 37:2350-2358. 10.1097/CCM.0b013e3181a3aa43, 19531944.
6. Pugin J. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 2007, 280:21-27; discussion 27-36, 160-164.
7. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD. GM-CSF to reverse sepsis-associated immunosuppression: a double-blind randomized placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180:640-648. 10.1164/rccm.200903-0363OC, 19590022.
8. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 2009, 37:2746-2752. 10.1097/CCM.0b013e3181ab858a, 19707128.
9. Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C, Crozon J, Faure A, Guillaume C, Marcotte G, Vulliez A, Monneuse O, Monneret G. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 2010, 14:R208. 10.1186/cc9331, 21092108.
10. Docke WD, Hoflich C, Davis KA, Rottgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, Nebe T, Engel A, Monneret G, Spittler A, Schmolke K, Reinke P, Volk HD, Kunz D. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 2005, 51:2341-2347. 10.1373/clinchem.2005.052639, 16214828.
11. Venet F, Lepape A, Monneret G. Clinical review: flow cytometry perspectives in the ICU: from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care 2011, 15:231.